SAFETY OF INFLIXIMAB AFTER LIVE VIRUS VACCINATION IN KAWASAKI DISEASE PATIENTS.

MLA

Lee, Aaron M., et al. “Safety of Infliximab After Live Virus Vaccination in Kawasaki Disease Patients.” Pediatric Infectious Disease Journal, vol. 36, no. 4, Apr. 2017, pp. 435–37. EBSCOhost, https://doi.org/10.1097/INF.0000000000001447.

APA

Lee, A. M., Burns, J. C., & Tremoulet, A. H. (2017). Safety of Infliximab After Live Virus Vaccination in Kawasaki Disease Patients. Pediatric Infectious Disease Journal, 36(4), 435–437. https://doi.org/10.1097/INF.0000000000001447

Chicago

Lee, Aaron M., Jane C. Burns, and Adriana H. Tremoulet. 2017. “Safety of Infliximab After Live Virus Vaccination in Kawasaki Disease Patients.” Pediatric Infectious Disease Journal 36 (4): 435–37. doi:10.1097/INF.0000000000001447.